Citius Pharmaceuticals- Warrants(02/08/2022) PEG Ratio

Citius Pharmaceuticals- Warrants(02/08/2022) (CTXRW) currently reports a PEG ratio of -0.8. That is below the Healthcare sector average of 2.56. Use the charts on this page to explore Citius Pharmaceuticals- Warrants(02/08/2022)'s PEG ratio history and peer comparisons.

Citius Pharmaceuticals- Warrants(02/08/2022)'s PEG ratio of -0.8 is lower than the Healthcare sector average of 2.56. That is roughly 131.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Citius Pharmaceuticals- Warrants(02/08/2022)'s market price to a fundamental measure such as earnings, sales, or book value. At -0.8, CTXRW can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -0.8, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.56. From there, open related valuation or income-statement pages for Citius Pharmaceuticals- Warrants(02/08/2022), and consider following CTXRW for alerts when major investors trade the stock.

Citius Pharmaceuticals- Warrants(02/08/2022) is classified in the Healthcare sector. On PEG ratio, it currently shows -0.8 versus a sector average near 2.56. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTXRW with unrelated industries.